Can Helicobacter pylori eradication prevent gastric carcinoma? Invitation to participate in the German-Austrian PRISMA study;Helicobacter pylori-eradikation zur prophylaxe des magenkarzinoms? Einladung zur Deutsch-Österreichischen PRISMA-studie

Leber Magen Darm

Volumn 28, Issue 3, 1998, Pages 128-135

  Stolte, M ^a   Bayerdorffer E ^b   Miehlke, S ^b   Meining, A ^c   Dragosics, B ^d   Oberhuber, G ^e   Malfertheiner, P ^f  

^a INSTITUTE OF PATHOLOGY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Gesundheitszentrum Wien Süd WGKK   (Austria)

^e UNIVERSITY OF VIENNA   (Austria)

^f UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Gastric carcinoma; Helicobacter pylori; Prevention

Indexed keywords

ARTICLE; AUSTRIA; CANCER PREVENTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GERMANY; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; OBSERVATION; RANDOMIZED CONTROLLED TRIAL; STOMACH ANTRUM; STOMACH CARCINOMA;

EID: 0031816684     PISSN: 03008622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. IARC. Schistosomes, liver flukes and Helicobacter pylori. In IARC monographs on the evaluation of carcinogenic risks to humans. Vol 61 WHO Publications, Geneva 1994.
2. Graham DY. Can therapy ever be denied for Helicobacter pylori infection?. Gastroenterol 1997; 113: 113-7.
3. Lee A. Helicobacter pylori and future research. Gastsoenterol 1997; 113: 167-9.
4. Correa P. Precursors of gastric and esophageal cancer. Cancer 1982; 50: 2554-6.
5. Correa P, Fox J, Fontham E, Ruiz B, Lin Y, Zavala D, Taylor N, Mackinley D, de Lima E, Portilla H, Zarama G. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990; 66: 2569-74.
6. Parsonnet J, Friedman GD, Vandersteen D. Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
7. Forman D, Newell DG, Fullerton F, Yarnell YWG., Stacey, AR, Wald N, Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Brit Med J 1991; 302: 1302-5.
8. Fiocca R, Luinetti O, Villani L, Chiaravalli A, Cornaggia M, Stella, G, Perego M, Trespi E, Solcia E. High incidence of Helicobarter pylori colonization in early gastric cancer and the possible relationship to carcinogenesis. Eur J Gastroenterol Hepatol 1993; 5 (suppl 2): 2-8.
9. Asaka M, Kimura T, Kato M, Kudo M, Miki K, Ogoshi K, Kato T, Tatsuta M, Graham DY. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 1994; 73: 2691-4.
10. Rokkas T, Papatheodorou G, Karameris A, Mavgeorgis A, Kalogeropoulos N, Giannikos N. Helicobacter pylori infection and gastric juice vitamin C levels. Dig Dis Sci 1995; 40: 615-21.
11. Sobala GM, Pignatelli B, Schorah CJ, Bartsch H, Sanderson M, Dixon MF, Shires S, King RFG, Axon ATR. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid, and total bile acids in the gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis 1991; 12: 193-8.
12. Lynch DAF, Mapstone NP, Clarke AMT, Sobala GM, Jackson P, Morrison L, Dixon MF, Quirke P, Axon ATR. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut 1995; 36: 346-50.
13. Bechi P, Balzi M, Becciolini A, Maugeri A, Casini Raggi C, Amorosi A, Die. R. Helicobacter pylori and cell proliferation of the gastric mucosa: possible implications for gastric carcinogenesis. Am J Gastroenterol 1996; 91: 271-6.
14. Davies GR, Banatvala N, Collins CE, Sheaff MT, Abdi Y, Clements L, Rampton DS. Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol 1994; 29: 419-24.
15. Wilson KT, Ramanujam KS, Mobley HL, Musselman RF, James SP, Meltzer SJ. Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line. Gastroenterol 1996; 111: 1524-33.
16. IARC Scientific Publications. In Whelan SL, Parkin DM, Masuyer E (Hrsg.). Trends in cancer incidence and mortality. Vol. 102 Lyon WHO Publications, 1993
17. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Haruma K, Sumii K, Kajiyama G. Effect of Helicobacter pylon eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Canc Epidem Biemarkers & Prev 1997; 6: 639-42.
18. Hansson LE, Nyren O, Hesing AW, Evans DJ, Lindgren A, Bergstöm R, Josefsson S, Chow WH, Fraumeni JF, Adami HO. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335: 242-9.
19. Boeing H, Jedrychowski W, Wahrendorf J, Popiela T, Tobias-Adamczyk B, Kulig A. Dietary risk factors in intestinal and diffuse types of stomach cancer: a multicenter casecontrol study in Poland. Canc Caus Control 1991; 2: 227-33.
20. Personnet J, Friedman GD, Orentreich N, Vogelman H. Risk of gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40: 297-301.
21. + Helicobacter pylori strains. J Clin Microbiol 1995; 33: 1496-1500.
22. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 3554-60.
23. Morson BC. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 1955; 9: 377-85.
24. Solcia E, Fiocca R, Luinetti O, Villani L, Padovan L, Calistri D, Ranzani GN, Chiaravalli A, Capella C. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996; 20: 8-22.
25. Hattori T. Development of adenocarcinomas of the stomach. Cancer 1986; 57: 1528-34.
26. Filipe MI, Munoz N, Matko I, Kato I, Pompe-Kim V, Jutersek A, Teuchmann S, Benz M, Prijon T. Intestinal metaplasia and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994; 57: 324-9.
27. van der Hulst RWM, van der Ende A, Dekker FW, ten Kate FJW, Weel JFL, Keller JJ, Kruizinga SP, Dankert J, Tytgat GNJ. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterol 1997; 113: 25-30.
28. Annibale B, Marignani M, Azzoni C, D'Ambra G, Caruana P, D'Adda T, Delle Fave G, Bordi C. Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter 1997; 2: 57-64.
29. O'Connor F, Buckley M, Sweeney E, O'Morain C. Intestinal metaplasia and the gastric cancer cascade. Gastroenterol 1996; 110: A214.
30. Cahill RJ, Sant S, Beattie S, Hamilton H, O'Morain C. Helicobacter pylori and increased epithelial proliferation: a risk factor for cancer. Eur J Gastroenterol Hepatol 1994: 6: 1123-7.
31. Sobala GM, Schorah CJ, Shires S, Lynch DAF, Gallacher B, Dixon MF, Axon ATR. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 1993; 34: 1038-41.
32. Götz JM, Thio JL, Verspaget HW, Offerhaus GJA, Biemond I, Lamers CBHW, Veenendaal RA. Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases. Gut 1997; 40: 591-6.
33. Tatsuta M, Iishi H, Nakaizumi A, Okuda S, Taniguchi H, Ttsukuma H, Oshima A. Fundal atrophic gastritis as a risk factor for gastric cancer. Int J Cancer 1993; 53: 70-4.
34. Sipponen P. Atrophic gastritis as a premalignant condition. Ann Med 1989; 21: 287-90.
35. Lee A, Dixon MF, Danon SJ, Kuipers E, Mègraud F, Larsson H, Mellgard B. Local acid production and Helicobacter pylori: an unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol 1995; 7: 461-5.
36. El-Omar EM, Penman ID, Ardill JES, Chittajallu RS, Howie C, McColl KEL. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterol 1995; 109: 681-91.
37. Queiroz DMM, Mendes EN, Rocha GA, Moura SB, Resende LMH, Barbosa AJA, Coelho LGV, Passos MCF, Castro LP, Oliviera CA, Lima GF. Effect of Helicobacter pylori eradication on antral gastrin- and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Scand J Gastroenterol 1993; 28: 858-64.
38. Asaka M, Kimura T, Kudo M. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterol 1992; 102: 760-6.
39. Sipponen P, Kimura K. Intestinal metaplasia, atrophic gastritis and stomach cancer: trends over time. Eur J Gastroenterol Hepatol 1994; 6: 79-83.
40. Bayerdörffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995; 345: 1591-4.
41. Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B, Wündisch T, Ehninger G, Stolte M, Bayerdörffer E. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 1997; 89: 1350-5.